Dyslipidemia and reduced retinal layer thicknesses in mild to moderate non-proliferative diabetic retinopathy

被引:0
|
作者
Wu, Jingjing [1 ]
Chen, Yanrong [1 ]
Huang, Cuiting [1 ]
Wang, Yuqing [1 ]
Lin, Lingli [1 ]
Zhang, Zhaode [1 ]
机构
[1] Ningde Normal Univ, Dept Ophthalmol, Ningde Municipal Hosp, 13 Mindong East Rd, Ningde 352100, Fujian, Peoples R China
来源
关键词
Diabetic retinopathy; retinal nerve fiber layer; retinal ganglion cells; risk factors; OPTICAL COHERENCE TOMOGRAPHY; VASCULAR CHANGES; MACULAR EDEMA; SERUM-LIPIDS; NEURODEGENERATION; REPRODUCIBILITY; MELLITUS; PATHOGENESIS; DISEASE;
D O I
10.62347/EHTP6496
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: To investigate the changes in ganglion cell layer-inner plexiform layer (GCL-IPL) thickness and its association with peripheral blood indices in non-proliferative diabetic retinopathy (NPDR). Methods: In this crosssectional study, 132 participants were categorized into three groups: 30 healthy volunteers (control group), 50 diabetic patients with non-diabetic retinopathy (NDR group), and 52 patients with NPDR. Optical coherence tomography (OCT) was used to measure the retinal nerve fiber layer (RNFL) and GCL-IPL thicknesses in the macula. The associations between RNFL loss and systemic risk factors for DR, such as diabetes duration, triglyceride (TG), total cholesterol (TC), high-density lipoprotein (HDL), low-density lipoprotein (LDL), and hemoglobin A1c (HbA1c) were evaluated. Results: The average, superior, and nasal thicknesses in the NDR and NPDR groups were significantly thinner compared to the control group (P=0.002, 0.020, 0.090, respectively). Similarly, GCL-IPL thicknesses in the 3 mm and 6 mm zones of the NDR and NPDR groups were thinner than those in the control group (P=0.040, 0.022, 0.037, respectively). Temporal thicknesses in the 3 mm range of the NDR and NPDR groups were also thinner than in the control group (P=0.010). Superior RNFL thickness was positively correlated with HbA1c (r=0.200, P=0.044), and negatively correlated with HDL (r=-0.198, P=0.047). The average inferior and nasal GCL-IPL thicknesses were negatively correlated with TC across the 3 mm zone (r=-0.211, P=0.033; r=-0.224, P=0.023; r=-0.227, P=0.022). Additionally, the average thickness of GCL-IPL in the 6-mm range were positively correlated with the duration of diabetes (r=0.196, P=0.048). Conclusion: This study demonstrates that dyslipidemia in diabetic patients correlates with reductions in RNFL and GCL-IPL thicknesses, suggesting a role in the pathogenesis of diabetic retinopathy.
引用
收藏
页码:5718 / 5727
页数:10
相关论文
共 50 条
  • [31] Longitudinal OCTA changes in non-proliferative diabetic retinopathy
    Valikodath, Nita
    Le, David
    Li, Xiang
    Yao, Xincheng
    Lim, Jennifer I.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2021, 62 (08)
  • [32] Vitamin B Intervention in Non-Proliferative Diabetic Retinopathy
    Smolek, Michael
    Notaroberto, Neil
    Pradillo, Lisa
    Jaramillo, Arley
    Lee, Kaci
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [33] Treatment effects of captopril on non-proliferative diabetic retinopathy
    WANG Ning
    ZHENG Zhi
    JIN Hui-yi
    XU Xun
    中华医学杂志(英文版), 2012, (02) : 287 - 292
  • [34] Aqueous Humor Cytokines in Non-Proliferative Diabetic Retinopathy
    Obada, Otilia
    Pantalon, Anca Delia
    Rusu-Zota, Gabriela
    Haisan, Anca
    Lupusoru, Smaranda Ioana
    Constantinescu, Daniela
    Chiselita, Dorin
    MEDICINA-LITHUANIA, 2022, 58 (07):
  • [35] Proteomic Analysis of the Vitreous Body in Proliferative and Non-Proliferative Diabetic Retinopathy
    Van-An Duong
    Ahn, Jeeyun
    Han, Na-Young
    Park, Jong-Moon
    Mok, Jeong-Hun
    Kim, Tae Wan
    Lee, Hookeun
    CURRENT PROTEOMICS, 2021, 18 (02) : 143 - 152
  • [36] Longitudinal Change in Retinal Layer Thicknesses in Subjects with Proliferative Diabetic Retinopathy Treated with Intravitreal Afliberecept
    Velaga, Swetha Bindu
    Nittala, Muneeswar Gupta
    Brown, Tyler
    Hu, Zhihong
    Wykoff, Charles Clifton
    Ip, Michael S.
    Sadda, Srinivas R.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [37] Incidence and prevalence of moderate to severe non-proliferative diabetic retinopathy within an English Screening Programme
    Fletcher, Emily
    Kerby, Clareece R.
    Stratton, Irene Mary
    Sivaprasad, Sobha
    Bailey, Clare
    Masso-Gonzalez, Elvira
    Maruti, Sonia
    Ehrlich, Michael
    Chong, Victor
    Scanlon, Peter Henry
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2020, 61 (07)
  • [38] Non-invasive structural and metabolic retinal markers of disease activity in non-proliferative diabetic retinopathy
    Weisner, Gwen
    Blindbaek, Soren Leer
    Tang, Fang Yao
    Cheung, Carol Y.
    Henriksen, Jan Erik
    Stefansson, Einar
    Peto, Tunde
    Grauslund, Jakob
    ACTA OPHTHALMOLOGICA, 2021, 99 (07) : 790 - 796
  • [39] Treatment of non-proliferative diabetic retinopathy with defibrotide in NIDDM patients
    Grenga, R
    Giusti, C
    DeMattia, G
    Vingolo, EM
    Laurenti, O
    Pannarale, MR
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1997, 38 (04) : 1629 - 1629
  • [40] Severe Non-Proliferative Diabetic Retinopathy Associates with Higher Retinal Arteriolar and Venular Oxygen Saturation
    Weisner, G.
    Blindbaek, S. L.
    Henriksen, J. E.
    Stefansson, E.
    Peto, T.
    Grauslund, J.
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2018, 28 : 18 - 19